These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8712572)

  • 1. [Prevalence of HIV infection in Italian drug users attending drug treatment centers in the years 1990-92].
    Rezza G; Alliegro MB; De Rose A; Pezzotti P; Serafin I
    Ann Ist Super Sanita; 1995; 31(3):301-5. PubMed ID: 8712572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in HIV prevalence among drug-users attending public drug-treatment centres in Italy: 1990-2000.
    Suligoi B; Magliochetti N; Nicoletti G; Pezzotti P; Rezza G
    J Med Virol; 2004 May; 73(1):1-6. PubMed ID: 15042640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch.
    Lehman JS; Allen DM; Green TA; Onorato IM
    AIDS; 1994 Oct; 8(10):1465-9. PubMed ID: 7818818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trends in the prevalence and geographic distribution of HIV infection among Italian drug addicts in treatment provided by public assistance services during 1990-1994].
    Perria C; Magliocchetti N; Nicoletti G; Pezzotti P; Rezza G
    Ann Ig; 1996; 8(6):621-33. PubMed ID: 9312229
    [No Abstract]   [Full Text] [Related]  

  • 5. Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991.
    Rezza G; De Rose A; Dorrucci M; Arpino C; Serafin I
    Eur J Epidemiol; 1993 Nov; 9(6):663-6. PubMed ID: 8150071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated risk behaviour among drug users at drug rehabilitation centres.
    Fauziah MN; Anita S; Sha'ari BN; Rosli BI
    Med J Malaysia; 2003 Jun; 58(2):268-72. PubMed ID: 14569748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of human immunodeficiency virus infection in drug addicts assisted from 1991 to 1996 at a detoxification center in Castilla y Leon].
    Alba A; Terán A; Cuende JI; Sánchez S; González C
    Enferm Infecc Microbiol Clin; 1998 Apr; 16(4):169-74. PubMed ID: 9646560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection among substance abusers in Thanyarak Institute On Drug Abuse, Thailand, 1987-2002.
    Verachai V; Phutiprawan T; Sawanpanyalert P
    J Med Assoc Thai; 2005 Jan; 88(1):76-9. PubMed ID: 15960222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug abuse treatment as AIDS prevention.
    Metzger DS; Navaline H; Woody GE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):97-106. PubMed ID: 9722815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristics and risk factors for HIV infection among Beijing drug users in different settings.
    Wang H; Li G; Brown K; Smith K; Jin X; Dong R; Wang N
    Drug Alcohol Depend; 2011 Jan; 113(1):37-45. PubMed ID: 20728287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel surveillance and cross sectional survey on HIV infection prevalence: a comparative study.
    Kwesigabo G; Killewo JZ; Sandstrom A
    East Afr Med J; 1996 May; 73(5):298-302. PubMed ID: 8756031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV and related infections in Italian penal institutions: epidemiological and health organization note].
    Babudieri S; Starnini G; Brunetti B; Carbonara S; D'Offizi GP; Monarca R; Mazzarello G; Novati S; Casti A; Florenzano G; Quercia G; Iovinella E; Sardu C; Romano A; Dierna M; Vullo S; Pintus A; Maida I; Dori L; Ardita S; Mura MS; Andreoni M; Rezza G
    Ann Ist Super Sanita; 2003; 39(2):251-7. PubMed ID: 14587225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.